May 27, 2020
Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients
May 12, 2020
Acute Respiratory Distress Syndrome Pipeline Guide 2020
Apr 27, 2020
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Apr 14, 2020
COVID-19 ARDS Patients Added to Healios ONE-BRIDGE Study
Apr 02, 2020
Ampio Pharmaceutical's Application to the FDA for a Clinical Study of Ampion(TM) to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)
Mar 26, 2020
Regarding HLCM051 for Acute Respiratory Distress Syndrome (ARDS) Caused by COVID -19
Mar 13, 2020
ADVISORY: Online Media Briefing About Acute Respiratory Distress Syndrome and COVID-19 Set for Monday with ARDS Foundation and Dr. Michael Matthay
Mar 10, 2020
FibroGenesis Files Patent Using its Fibroblast Cell Therapy for Coronavirus (COVID-19) ARDS
Jan 21, 2020
DW Support Services Enhances Customer Experience With Localz
Oct 17, 2019
Acute Respiratory Distress Syndrome (ARDS) Market To Reach USD 934.8 Million By 2026 | Reports And Data
Aug 20, 2019
Aqualung Therapeutics Corporation Receives $225 Thousand Dollar National Institute of Health (NIH) Grant to Establish Biomarker Panel for Patients with Acute Respiratory Distress Syndrome
May 31, 2019
MorganFranklin Consulting Adds Managing Director Barbara Ard to Board of Directors
Oct 31, 2018
DW Partners with Headliner To Increase Video Production
Nov 02, 2017
Biomarck Announces First Patients Treated in Phase 2 Clinical Trial of BIO-11006 for Acute Respiratory Distress Syndrome (ARDS)
Jun 26, 2017
Acute Respiratory Distress Syndrome (ARDS) Forecast in 11 Major Markets 2017-2027 - Research and Markets